Lv4
660 积分 2023-07-30 加入
Hepatocellular carcinoma
21天前
已完结
CONSORT 2025 statement: updated guideline for reporting randomised trials
22天前
已完结
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
1个月前
已完结
Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma
1个月前
已完结
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
1个月前
已完结
Recurrence of Hepatocellular Cancer After Resection
1个月前
已完结
Comparison of perioperative outcomes between robotic-assisted and open resection for hepatic caudate lobe hemangioma: a single-center retrospective study
1个月前
已完结
Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors
2个月前
已完结
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
2个月前
已完结
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients
2个月前
已完结
皖公网安备34019202002308
